Lotus Pharmaceutical Co., Ltd. (TPE: 1795)

Lotus Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,688	1,771	1,983	1,605	1,489	1,277
Cash & Short-Term Investments	3,688	1,771	1,983	1,605	1,489	1,277
Cash Growth	79.67%	-10.71%	23.54%	7.82%	16.61%	24.79%
Accounts Receivable	7,242	6,384	4,651	3,266	2,747	2,267
Other Receivables	151.03	233.13	276.24	141.56	53.19	149.97
Receivables	7,393	6,617	4,927	3,407	2,801	2,417
Inventory	3,982	3,775	3,330	3,073	2,208	1,343
Other Current Assets	528.05	489.37	420.4	247.24	284.61	684.14
Total Current Assets	15,590	12,653	10,661	8,333	6,783	5,721
Property, Plant & Equipment	3,708	3,511	3,148	2,642	2,305	2,049
Long-Term Investments	2,991	3,048	2,158	301.73	412.85	458.06
Goodwill	6,308	5,670	5,668	5,586	5,896	5,910
Other Intangible Assets	5,387	5,487	5,910	2,971	3,177	2,102
Long-Term Accounts Receivable	176.38	152.6	-	-	-	-
Long-Term Deferred Tax Assets	427.58	411.69	390.12	310.82	364.61	378.65
Long-Term Deferred Charges	2,473	1,878	1,406	891.98	654.1	808.96
Other Long-Term Assets	172.76	180.28	185.33	185.35	161.12	767.4
Total Assets	37,234	32,992	29,526	21,222	19,753	18,195
Accounts Payable	877.63	670.8	1,403	747.55	1,732	934.67
Accrued Expenses	6.57	3.87	3.57	0.93	2.46	108.47
Short-Term Debt	689.49	510	155.92	1,377	410	460
Current Portion of Long-Term Debt	2,310	1,303	59.95	794.9	1,359	579.08
Current Portion of Leases	92.24	70.24	58.99	62.47	40.43	58.93
Current Income Taxes Payable	632.45	436.56	731.15	280.16	226.62	60.29
Current Unearned Revenue	181.91	132.85	183.08	132.01	132.1	65.05
Other Current Liabilities	1,355	1,397	3,297	931.26	980.66	834.03
Total Current Liabilities	6,145	4,524	5,893	4,326	4,883	3,101
Long-Term Debt	9,132	9,519	8,596	4,667	4,948	6,134
Long-Term Leases	216.82	182.2	46.82	43.41	76.58	115.9
Long-Term Unearned Revenue	30.88	45.33	65.92	85.96	111.78	104.04
Long-Term Deferred Tax Liabilities	790.21	721.2	448.4	304.15	144.69	172.25
Other Long-Term Liabilities	115.71	162.29	235.84	224.03	257.46	280.92
Total Liabilities	17,016	15,658	15,658	10,153	11,008	10,476
Common Stock	2,657	2,650	2,626	2,628	2,454	2,431
Additional Paid-In Capital	7,339	7,131	7,534	8,039	6,799	6,588
Retained Earnings	11,601	8,900	4,823	1,701	353.66	-652.94
Treasury Stock	-48.39	-51.1	-57.35	-57.75	-	-
Comprehensive Income & Other	-1,330	-1,295	-1,058	-1,241	-860.97	-624.22
Total Common Equity	20,219	17,334	13,868	11,069	8,745	7,742
Minority Interest	-	-	-	-	-	-23.51
Shareholders' Equity	20,219	17,334	13,868	11,069	8,745	7,719
Total Liabilities & Equity	37,234	32,992	29,526	21,222	19,753	18,195
Total Debt	12,440	11,585	8,918	6,944	6,834	7,348
Net Cash (Debt)	-8,752	-9,814	-6,935	-5,339	-5,345	-6,072
Net Cash Per Share	-33.29	-37.45	-26.50	-20.80	-21.95	-25.10
Filing Date Shares Outstanding	265.19	264.47	262.04	262.25	245.35	243.11
Total Common Shares Outstanding	265.19	264.47	262.04	262.25	245.35	243.11
Working Capital	9,445	8,129	4,768	4,007	1,900	2,621
Book Value Per Share	76.24	65.54	52.92	42.21	35.64	31.85
Tangible Book Value	8,524	6,177	2,291	2,512	-327.16	-269.55
Tangible Book Value Per Share	32.14	23.36	8.74	9.58	-1.33	-1.11
Land	621.85	622.55	622.31	615.49	654.22	656.01
Buildings	2,108	1,888	1,384	1,313	1,012	988.14
Machinery	1,898	1,826	1,547	1,408	1,324	1,238
Construction In Progress	620.52	639.41	1,077	675.22	608.86	275.6
Leasehold Improvements	103.63	71.01	87.87	78.26	85.33	85.1

Source: S&P Capital IQ. Standard template. Financial Sources.